What’s the future now for CNS2

Now that Rapastinel a flop, what’s the future for CNS2? I know the company already has about 20 in place in some markets. Don’t think need three reps selling Vraylar in same offices

 

Expanded before getting Phase 3 results.... good move upper management.

 

Bleak.

 

Bye bye, dummy primary care rep

 

A decent severance package coming your way

A removal of the bronze handcuffs for the opportunity to find silver or gold elsewhere

 

What an outdated sales model to have three reps calling on psych offices. I sure hope company not stupid enough to add more CNS2 reps.

 

very unnecessary!

 

Weren’t they put in place to gear up for rapastinal launch that now isn’t going to happen. Smart mover upper management. Now we apparently have a bunch of higher paid reps clogging up offices

 

Everything you said is correct but we aren’t higher paid reps lol

 

I didn’t even know there was a CNS2 position. Wonder how they decided where to put them. Must be in markets where access wide open so lucky them if that’s the case cuz I have a hard time getting to see 4 live bodies in a day the way it is.

 

Find another division quick

 

Yeah, these dopes took the job and didn’t receive a raise.

 

In the markets that are adding CNS2 reps, they should definitely pull the psych providers off the primary care reps panels and just pay them on primary care scripts. Let the CNS specialists who have more experience call on the psych market like every other company has done forever. Why have a CNS role if pcp reps calling on them too. Allergan way behind the times

 

specialty reps should be only reps calling on psych. Let the PCR reps sell to all those primary care doctors corporate thinks they are going to get to prescribe Vraylar

 

will the company be adding more CNS2 reps? Sounds like they would rather spend resources hiring contract people to sell Vraylar to low volume primary Care doctors. Makes no sense whatsoever. Vraylar is a specialty drug and reps selling it need to have years experience selling in CNS in order to be a respected and knowledgeable rep. What is upper management thinking???

 

Good lord we don’t need more bodies selling Vraylar in primary care. Such a stupid plan and waste of resources. In territories that have a CNS2 We need to remove primary care targets from their panels and have the PCR rep focus on the primary care market and take psych providers off their panels.

 

Is there plans to add more CNS2 reps? Seems odd there are only 20 in company right now. Thinking it’s a pilot program to see if it generates more sales

 

CNS Specialty Managers leaving all over??? What's up with that? That can't be a good sign...